Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma-Reference-Cited by-同舟云学术

Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma

Author:

Castillo Jorge J.¹^ORCID,Reagan John L.²,Sikov William M.³,Winer Eric S.²

Affiliation:

1. Division of Hematologic Malignancies; Dana-Farber Cancer Institute; Harvard Medical School; Boston MA USA

2. Division of Hematology and Oncology; The Miriam Hospital; The Warren Alpert Medical School of Brown University; Providence RI USA

3. Program in Women's Oncology; Women and Infants Hospital; The Warren Alpert Medical School of Brown University; Providence RI USA

Publisher

Wiley

Subject

Hematology

Link

Reference13 articles.

5. Plasmablastic lymphoma: a systematic review;Castillo;The Scientific World Journal,2011

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Clinical Experience on Proteasome Inhibitors in Cancer;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

4. Plasmablastic Lymphoma;Reference Module in Biomedical Sciences;2023